MTHFR AND ApoE genetic variants association with sudden sensorineural hearing loss

Am J Otolaryngol. 2019 Mar-Apr;40(2):260-264. doi: 10.1016/j.amjoto.2018.10.015. Epub 2018 Oct 29.

Abstract

Hypothesis: Although the pathogenesis of sudden sensorineural hearing loss (SSNHL) is not clear, however several causes including genetic factors seems to be implicated. We hypothesized that common genetic variants might be involved in SSNHL.

Background: SSNHL is known to be an idiopathic disease because the causative factors have not been identified. Several causes including genetic and viral infection besides immune system reaction, neurological disorders, medications, etc. have been previously reported. We examined the association between ApoE and MTHFR gene variants in SSNHL.

Methods: This study includes case-control scheme encompassing a total of 177 individuals, include patients inflicted with SSNHL and healthy subjects as control group. Genotyping of MTHFR and ApoE variants was conducted by PCR - RFLP method.

Result: Our study showed that MTHFR rs1801133 allele frequency is significantly different between cases and controls. Also genotype distribution of ApoE was significantly different between patients and healthy controls.

Conclusions: MTHFR C677T and ApoE gene variant may be associated with sudden sensorineural hearing loss in an Iranian population.

Keywords: Apolipoprotein E; Genetic variation; Methylenetetrahydrofolate reductase; Sudden sensorineural hearing loss.

MeSH terms

  • Adult
  • Apolipoproteins E / genetics*
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genetic Association Studies*
  • Genetic Variation / genetics*
  • Genotype
  • Genotyping Techniques / methods
  • Hearing Loss, Sensorineural / genetics*
  • Hearing Loss, Sudden / genetics*
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length

Substances

  • Apolipoproteins E
  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)